NCT03564158 Evaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03562117 Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function Status COMPLETED Phase PHASE1
NCT03511105 Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge Model Status TERMINATED Phase PHASE1
NCT03497845 Assess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted With AS03 or MF59 Status COMPLETED Phase PHASE2
NCT03384407 Recovery and Lifespan of Red Blood Cells From Pathogen-reduced, Stored Blood Units Status UNKNOWN Phase NA
NCT03372603 A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough Status TERMINATED Phase PHASE1/PHASE2
NCT03329092 A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. Status COMPLETED Phase PHASE3
NCT03014089 Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT02989194 Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A Status COMPLETED Phase PHASE2
NCT02964325 Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia Status TERMINATED Phase NA
NCT02918006 A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine Status COMPLETED Phase PHASE2
NCT02905435 Assessment of Safety and Effectiveness of Biodegradable Temporizing Matrix in the Treatment of Deep Burn Skin Injuries Status COMPLETED Phase NA
NCT02839330 A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age Status COMPLETED Phase PHASE3
NCT02680002 Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant Status COMPLETED Phase PHASE2
NCT02605122 Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia Status TERMINATED Phase PHASE2/PHASE3
NCT02474589 A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat Status COMPLETED Phase PHASE3
NCT02469857 Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections Status COMPLETED Phase PHASE3